170546 ⎘
Assays involving biological materials from specific organisms or of a specific nature Translation products from oncogenes
DCIS RECURRENCE AND INVASIVE BREAST CANCER
#2TRANSFERRIN RECEPTOR BINDING PROTEINS FOR TREATING BRAIN TUMORS
#3SINGLE-DOMAIN HIGH AFFINITY ANTIBODIES AND METHODS OF USE THEREOF
#4METHODS OF DIAGNOSING, DETERMINING THE PROGRESSION OF, AND TREATING A PROSTATE CANCER
#5Method for Evaluating Clinical Relevance of Genetic Variance
#6MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS
#7T CELL AND NK CELL ENGAGERS
#8ACTIVATED RAS AS THERAPEUTIC AND DIAGNOSTIC TARGET FOR NEUROFIBROMATOSIS AND USE THEREOF
#9METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#10POLYNUCLEOTIDES ENCODING INTEGRIN BETA-6 AND METHODS OF USE THEREOF
#11METHODS FOR ASSESSING AN IMMUNE RESPONSE AND PREDICTING CANCER RECURRENCE AND ASSESSMENT OF CURRENT AND PRIOR CANCER STATUS
#12SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#13METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR
#14HER3-BINDING ANTIBODY-DRUG CONJUGATE
#15HER2 VACCINE COMPOSITION
#16BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER
#17TEST METHOD, OF DIVIDING BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) INTO SUBTYPES
#18COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES
#19Method for Predicting Effectiveness of Angiogenesis Inhibitor
#20Markers for the early detection of colon cell proliferative disorders
#21DCIS RECURRENCE AND INVASIVE BREAST CANCER
#22Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer
#23Anti-HER2 Antibodies and Immunoconjugates
#24PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATHWAY BIOMARKERS
#25Methods of Enhancing Immunogenicity of Cancers
#26Method of selection for treatment of subjects at risk of invasive breast cancer
#27MICROFLUIDIC CHIP SUITABLE FOR CAPTURING CIRCULATING TUMOUR CELLS
#28METHOD OF SELECTION FOR TREATMENT OF SUBJECTS AT RISK OF INVASIVE BREAST CANCER
#29Methods of diagnosing, determining the progression of, and treating a prostate cancer
#30Agents and methods for treating pancreatic ductal adenocarcinomas
#31Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
#32ANTIBODY QUANTIFICATION IN BIOLOGICAL SAMPLES
#33HER2 S310F SPECIFIC ANTIGEN-BINDING MOLECULES
#34METHOD FOR FORECASTING ARRIVAL OF DRUG INSIDE DISEASED TISSUE
#35METHODS OF TREATING CANCER
#36METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES
#37Method for Rapid Accurate Dispensing, Visualization and Analysis of Single Cells
#38Diagnosis method of multiple sclerosis
#39USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF CD9, AKT AND MOLECULES OF THE TETRASPANIN SIGNALLING NETWORK
#40DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
#41ANTIBODY FOR HER2 CONCOMITANT DIAGNOSIS IMMUNOHISTOCHEMICAL DETECTION AND APPLICATION THEREOF
#42METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#43PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
#44AGENTS AND METHODS FOR TREATING PANCREATIC DUCTAL ADENOCARCINOMAS
#45Methods of BH3 profiling
#46MULTIPLEX HER2 AND ESTROGEN RECEPTOR CO-STAINING ASSAYS FOR DETECTING TUMOR HETEROGENEITY
#47SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER
#48MOLECULAR PROFILING FOR CANCER
#49Method for treating complications related to acute or chronic hyperglycemia
#50Noninvasive molecular controls
#51Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
#52Anti-HER2 Antibodies and Immunoconjugates
#53Method for rapid accurate dispensing, visualization and analysis of single cells
#54Method for Predicting Effectiveness of Angiogenesis Inhibitor
#55T cell receptors recognizing HLA-CW8 restricted mutated KRAS
#56Detection of arginine methylation of EGFR for prediction of resistance to therapy
#57DIAGNOSTIC AND THERAPEUTIC METHODS FOR KRAS POSITIVE CANCERS
#58Cell response assay for cancer and methods of producing and using same
#59DISCOVERY AND VALIDATION OF CANCER BIOMARKERS USING A PROTEIN ANALYSIS METHODOLOGY TO ANALYZE SPECIMENS
#60Predicting response to alvocidib by mitochondrial profiling
#61NOVEL METHODS FOR TREATING CANCER
#62Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
#63STEAP3 as a biochemical marker of red blood cell storage and toxicity
#64Anti-HER2 antibodies and immunoconjugates
#65Method for the diagnosis, prognosis and treatment of lung cancer metastasis
#66COMPOSITIONS AND METHODS FOR SCREENING PEDIATRIC GLIOMAS AND METHODS OF TREATMENT THEREOF
#67METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR
#68T cell receptors recognizing HLA-Cw8 restricted mutated KRAS
#69Predicting response to alvocidib by mitochondrial profiling
#70DIAGNOSIS MARKER FOR RARE HEMATOPOIETIC TUMOR, TEST METHOD, THERAPEUTIC AGENT, AND SCREENING METHOD
#71Cyclic peptide binder against oncogenic K-Ras
#72Methods and materials for identifying therapeutic response in chronic myeloid leukemia
#73HER2 peptide regents and methods
#74Methods and reagents for analyzing protein-protein interfaces
#75Methods and reagents for analyzing protein-protein interfaces
#76Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives
#77NOVEL METHODS FOR TREATING CANCER
#78Method for screening for cancer therapeutic agent
#79Methods for detecting prostate cancer by determining the ratio of early to late endosomal markers
#80In vitro selection of formaldehyde cross-linking aptamers
#81DIAGNOSTIC AND PROGNOSTIC METHODS FOR BARRETT'S ESOPHAGUS
#82Agents and methods for treating pancreatic ductal adenocarcinomas
#83MOLECULAR PROFILING FOR CANCER
#84RADIO-LABELLED ANTIBODY FRAGMENTS FOR USE IN THE PROGNOSIS, DIAGNOSIS OF CANCER AS WELL AS FOR THE PREDICTION OF CANCER THERAPY RESPONSE
#85ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
#86Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#87Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
#88Steap3 as a biochemical marker of red blood cell storage and toxicity
#89Anti-ErbB antibodies and methods of use thereof
#90DIAGNOSIS OF CANCER
#91Discovery and validation of cancer biomarkers using a protein analysis methodology to analyze specimens
#92KRAS MUTATIONS AND RESISTANCE TO ANTI-EGFR TREATMENT
#93Method For Predicting Effectiveness Of Angiogenesis Inhibitor
#94USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#95Anti-HER2 antibodies and immunoconjugates
#96Specific biomarker set for non-invasive diagnosis of liver cancer
#97SRM/MRM Assays
#98Methods for breast cancer treatment
#99CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME
#100Methods and reagents for analyzing protein-protein interfaces
#101Quantifying met protein for cancer treatment
#102METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA
#103Beef-specific age determination marker containing the p21 protein
#104MULTIPLEX HER2 AND ESTROGEN RECEPTOR CO-STAINING ASSAYS FOR DETECTING TUMOR HETEROGENEITY
#105Method for detecting an FGFR3/TACC3 fusion protein, or encoding gene thereof
#106METHODS FOR DETECTING ALLOSTERIC MODULATORS OF PROTEIN
#107Methods for treating cancer
#108POLYP RECURRENCE
#109Predicting response to alvocidib by mitochondrial profiling
#1105-amino-quinoline-8-carboxamide derivatives as 5-HT4 receptor agonists
#111Detection of arginine methylation of EGFR for prediction of resistance to therapy
#112Cyclic peptide binder against oncogenic K-Ras
#113CMET protein SRM/MRM assay
#114Method for rapid accurate dispensing, visualization and analysis of single cells
#115Methods and Devices for Detecting Kidney Damage
#116METHOD OF ENHANCING HEMATOPOIETIC CELL TRANSPLANTATION
#117Methods of BH3 profiling
#118NGAL AND URINARY TRACT INFECTION
#119METHODS FOR DETECTING PROSTATE CANCER
#120HER2-specific monoclonal antibodies and conjugates thereof
#121ELISA detection of urine DEK to predict and diagnose bladder cancer in humans
#122Anti-HER2 antibodies and immunoconjugates
#123BIOMARKERS FOR PREDICTING RESPONSE OF DLBCL TO TREATMENT WITH A BTK INHIBITOR
#124Drug selection for non-small cell lung cancer therapy
#125Method for the Prognosis and Treatment of Renal Cell Carcinoma Metastasis
#126Treatment of Acute Tubular Necrosis or Acute Tubule-Interstitial Nephropathy
#127Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
#128Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#129Methods and compositions for detection of targets for autoimmune disease
#130Methods of Using Biomarkers for the Treatment of Cancer by Modulation of BCL2 Expression
#131METHODS OF IDENTIFYING COMPOUNDS FOR TREATING DEPRESSION AND OTHER RELATED DISEASES
#132Methods of Treating Breast Cancer with Anthracycline Therapy
#133METHODS AND COMPOSITIONS FOR DETECTION OF TARGETS INVOLVED IN CANCER METASTASIS
#134Methods and compounds for increasing threonyl-tRNA synthetase activity
#135Method for the diagnosis, prognosis and treatment of lung cancer metastasis
#136COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF DISORDERS RELATED TO ALTERATIONS OF MYH9
#137METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH QUINOLINE DERIVATIVES
#138DOSE-RESPONSE MEDICAL OUTCOME MODEL PREDICTOR SYSTEM AND METHOD
#139Methods and compositions for identifying, diagnosing, and treating neuroblastoma
#140Anti-c-met antibodies
#141MULTIFUNCTIONAL METALLIC NANOSTRUCTURE AND METHOD FOR MANUFACTURING THE SAME
#142TEST FOR DIAGNOSING RESISTANCE TO AZACITIDINE
#143DETECTION OF PROSTATE AND BLADDER CANCER
#144Method for detecting cervical dysplasia
#145Methods for identifying modulators of Ras using nonlinear techniques
#146Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#147SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4)
#148Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject
#149Molecular subtyping, prognosis and treatment of prostate cancer
#150P28GANK monoclonal antibody and peptides for preparation thereof and use thereof
#151Methods and compositions for use with K-ras mediated disorders
#152Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer
#153Methods of treating breast cancer with anthracycline therapy
#154Biomarker panels for assessing radiation injury and exposure
#155BEEF-SPECIFIC AGE DETERMINATION MARKER CONTAINING THE P21 PROTEIN
#156Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject
#157Treatment and prevention of dengue virus infections
#158COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CARCINOMA
#159RECQL4/RECQL4 VARIANT-P53 COMPLEX FOR ALTERED MITOCHONDRIAL FUNCTION IN ROTHMUND-THOMSON SYNDROME
#160METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER
#161FUSION ANALYTE CYTOMETRIC BEAD ASSAY, AND SYSTEMS AND KITS FOR PERFORMING THE SAME
#162Method for Determining the Cbl-b Expression
#163IDENTIFICATION OF SIGNATURE GENES ASSOCIATED WITH HEPATOCELLULAR CARCINOMA
#164METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#165BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS
#166Methods and Devices for Detecting Kidney Transplant Rejection
#167Monoclonal antibodies against osteopontin
#168METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#169ORGANIC COMPOUNDS
#170COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF CANCER
#171Devices for Detecting Renal Disorders
#172Methods and Devices for Detecting Kidney Damage
#173Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#174Computer Methods and Devices for Detecting Kidney Damage
#175Methods and devices for detecting obstructive uropathy and associated disorders
#176Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#177Detection of gleevec resistance
#178Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#179METHODS AND KITS FOR DETECTING TUMOR-SPECIFIC FUSION PROTEINS
#180Methods and Compositions for Identifying, Diagnosing, and Treating Neuroblastoma
#181Marks as modifiers of the p53 pathway and methods of use
#182EXPRESSION PROFILE OF PROSTATE CANCER
#183c-MET kinase binding proteins
#184HADHs as Modifiers of the p21 Pathway and Methods of Use
#185MN/CA IX and cancer prognosis
#186DISCOVERY AND VALIDATION OF CANCER BIOMARKERS USING A PROTEIN ANALYSIS METHODOLOGY TO ANALYZE SPECIMENS
#187METHODS FOR IDENTIFYING AGENTS THAT MODULATE APOPTOSIS IN CELLS THAT OVER-EXPRESS A BCL-2 FAMILY MEMBER PROTEIN
#188PROGNOSTIC MARKER FOR BREAST CANCER AND COMPOSITION FOR INDUCING OBESITY COMPRISING HCCR-1
#189Quantitative Assays for Ras p21 in Body Fluids
#190Biomarkers for chronic vascular dysfunction
#191SCDs as modifiers of the p53 pathway and methods of use
#192PREVENTIVE OR REMEDY FOR ER-NEGATIVE AND HER2-NEGATIVE BREAST CANCER AND METHOD OF SCREENING THE SAME
#193UL97 INHIBITORS FOR TREATMENT OF PROLIFERATIVE DISORDERS
#194METHODS OF DIAGNOSIS OF SPINAL MUSCULAR ATROPHY AND TREATMENTS THEREOF
#195IMMUNE REACTIVITY TO HER-2/NEU PROTEIN FOR DIAGNOSIS AND TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/NEU ONCOGENE IS ASSOCIATED
#196Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
#197METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#198Diagnostic test for renal injury
#199METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#200Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
#201NON-SMALL CELL LUNG CANCER-RELATED GENE, ANLN, AND ITS INTERACTION WITH RhoA
#202Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
#203DUB3 as a Cancer Therapy Target
#204ORGANIC COMPOUNDS
#205KITS FOR DETECTING CERVICAL DYSPLASIA
#206MN/CA IX and cancer prognosis
#207Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
#208METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#209ZEBRAFISH MODEL OF MLL LEUKEMOGENESIS
#210Gene Marker and Use Thereof
#211Detection of gleevec resistance
#212Pyrazolo [1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
#213RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
#214Methods of diagnosis of spinal muscular atrophy and treatments thereof
#215Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IX's Coexpression with Her-2/neu/c-erbB-2, and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
#216Monoclonal antibodies against osteopontin
#217Soluble form of carbonic anhydrase IX (S-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/NEU/C-ERBB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
#218Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes
#219MARKs as Modifiers of the p53 Pathway and Methods of Use
#220SCDs As Modifiers of the p53 Pathway and Methods of Use
#221Detection of gleevec resistant mutations
#222Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated
#223Methods for identifying chemical modulators of Ras superfamily GTPase activity
#224METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#225Sppls as Modifiers of the P53 Pathway and Methods of Use
#226Foldable polymers as probes
#227Detection of gleevec resistant mutations
#228Vav inhibition in graft rejection
#229MN/CA IX and cancer prognosis
#230Methods for identifying agents that modulate apoptosis in cells that over-express a Bcl-2 family member protein
#231c-MET kinase binding proteins
#232LIMKs as modifiers of p53 pathway and methods of use
#233Organic compounds
#234Methods of identifying an agent that modulates an interaction between 53BP1 and histone H3, and uses thereof
#235Rabs as modifiers of the p53 pathway and methods of use
#236Flj20647s as modifiers of the p21 pathway and methods of use
#237Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
#238Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
#239Method of screening for protein inhibitors and activators
#240c-Met kinase binding proteins
#241Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
#242Method for the early detection of renal injury
#243Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
#244Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated
#245HADHs as modifiers of the p21 pathway and methods of use
#246HADHs as modifiers of the p21 pathway and methods of use
#247Chds as modifiers of the p53 pathway and methods of use
#248Dgks as modifiers of the p53 pathwha and methods of use
#249Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes